Sunny Pharmtech Inc. (TPEX:6676)

Taiwan · Delayed Price · Currency is TWD

11.15

-0.30 (-2.62%)

Sep 15, 2026, 1:34 PM CST

Market Cap	1.94B -27.5%
Revenue (ttm)	233.36M -19.6%
Net Income	-325.13M
EPS	-2.14
Shares Out	169.68M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	192,998
Open	11.40
Previous Close	11.45
Day's Range	10.95 - 11.40
52-Week Range	10.90 - 19.10
Beta	0.29
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2026

About Sunny Pharmtech

Sunny Pharmtech Inc. engages in the research, development, and sale of new and generic drug formulations and raw materials in Taiwan, the United States, and internationally. It offers lidocaine ointment that can be used as an anesthetic lubricant for intubation, which temporarily relieves pain associated with minor burns, sunburn, skin abrasions, and insect bites; cyanocobalamin injection for use in vitamin B12 deficiency and pernicious anemia caused by malabsorption; nitrofurantoin capsules for urinary tract infection; and aminocaproic acid ta... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2014

Employees 160

Stock Exchange Taipei Exchange

Ticker Symbol 6676

Full Company Profile

Financial Performance

In 2025, Sunny Pharmtech's revenue was 253.01 million, a decrease of -39.47% compared to the previous year's 418.01 million. Losses were -302.05 million, 93.6% more than in 2024.

Financial Statements